People Aren’t Asking About Drugs. They’re Asking If Their Lives Still Work.
Spend enough time in the DrugChatter logs and a pattern emerges. It’s not pharmacology. It’s not even really medicine. It’s […]
Spend enough time in the DrugChatter logs and a pattern emerges. It’s not pharmacology. It’s not even really medicine. It’s […]
In theory, digital health queries should track clinical reality: drug–drug interactions, dosing guidance, adverse effects, and regulatory questions. In practice,
While DrugChatter is a specialized platform for medication discussions, many of the most surprising side effects surfaced by its users
Summary:Patient interest clusters heavily around drug–drug interactions, food effects, and therapeutic alternatives. Statins (especially Lipitor), biologics like Cosentyx, and common
Scroll through enough patient forums and a pattern emerges: people aren’t just asking about side effects—they’re experimenting in real time.
There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic
The correlation had been hiding in plain sight for two years before anyone in pharmaceutical commercial analytics thought to look
Somewhere right now, a patient is asking an AI chatbot whether their oncology drug causes liver failure. The chatbot is
Every time ChatGPT answers a drug question, it may be doing something no FDA-approved ad campaign ever could — and
The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a
Every morning, thousands of pharmaceutical field reps walk into physician offices carrying approved messaging, printed leave-behinds, and CRM notes from
By the time your next drug launches, a chatbot will already have an opinion about it — and 40 million